Group One Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,602,000
Closed -$1.42M 8298
2022
Q4
$1.42M Sell
1,602,000
-7,400
-0.5% -$9.82K ﹤0.01% 2123
2022
Q3
$2.53M Sell
1,609,400
-191,900
-11% -$435K 0.01% 1705
2022
Q2
$3.62M Sell
1,801,300
-61,000
-3% -$105K 0.01% 1543
2022
Q1
$4.34M Sell
1,862,300
-3,388,400
-65% -$10.6M ﹤0.01% 1662
2021
Q4
$24.4M Buy
5,250,700
+282,300
+6% +$1.75M 0.02% 585
2021
Q3
$37.9M Buy
4,968,400
+204,200
+4% +$1.73M 0.04% 367
2021
Q2
$46.2M Sell
4,764,200
-658,200
-12% -$5.24M 0.06% 276
2021
Q1
$44.8M Sell
5,422,400
-1,483,500
-21% -$15.7M 0.07% 256
2020
Q4
$47.1M Buy
6,905,900
+1,456,300
+27% +$11.7M 0.08% 198
2020
Q3
$60.8M Buy
5,449,600
+2,737,200
+101% +$25.1M 0.19% 74
2020
Q2
$17M Buy
2,712,400
+2,178,100
+408% +$8.34M 0.08% 267
2020
Q1
$983K Buy
534,300
+195,900
+58% +$564K 0.01% 1537
2019
Q4
$1.14M Buy
338,400
+82,200
+32% +$196K 0.01% 1759
2019
Q3
$548K Sell
256,200
-16,100
-6% -$37.5K ﹤0.01% 2256
2019
Q2
$727K Buy
272,300
+40,900
+18% +$147K 0.01% 1819
2019
Q1
$1.1M Buy
231,400
+207,800
+881% +$545K 0.01% 1340
2018
Q4
$57K Buy
23,600
+21,200
+883% +$69.2K ﹤0.01% 3493
2018
Q3
$11K Sell
2,400
-81,700
-97% -$453K ﹤0.01% 4634
2018
Q2
$606K Sell
84,100
-82,100
-49% -$558K 0.01% 2141
2018
Q1
$856K Buy
166,200
+141,000
+560% +$1M 0.01% 1641
2017
Q4
$96K Buy
25,200
+21,700
+620% +$56.5K ﹤0.01% 3388
2017
Q3
$6K Buy
+3,500
New +$6.42K ﹤0.01% 4445
2017
Q2
Sell
-4,100
Closed -$16K 5231
2017
Q1
$16K Hold
4,100
﹤0.01% 3969
2016
Q4
$20K Sell
4,100
-18,300
-82% -$110K ﹤0.01% 3705
2016
Q3
$173K Buy
22,400
+4,900
+28% +$33K ﹤0.01% 2570
2016
Q2
$98K Buy
17,500
+15,000
+600% +$95.9K ﹤0.01% 2880
2016
Q1
$13K Sell
2,500
-57,000
-96% -$331K ﹤0.01% 3929
2015
Q4
$518K Sell
59,500
-75,000
-56% -$633K 0.01% 1797
2015
Q3
$1.13M Buy
134,500
+127,300
+1,768% +$2.03M 0.02% 1152
2015
Q2
$127K Buy
7,200
+6,500
+929% +$83.5K ﹤0.01% 2893
2015
Q1
$8K Buy
+700
New +$8.1K ﹤0.01% 4240

Other funds holding SRNE

Group One Trading's SRNE Position: Q4 2020 in Review

Group One Trading sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2020, closing a stake of 3,697 shares — an estimated $29.7K sold.

Group One Trading first reported a position in SRNE in Q1 2015 and held it in 15 quarters. The position peaked at $391K in Q3 2018. 219 funds tracked by Wall St. Rank hold SRNE as of Q4 2020.

  • Group One Trading reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Group One Trading sold 3,697 Sorrento Therapeutics, Inc. shares in Q4 2020, an estimated $29.7K.
  • Group One Trading first reported a position in Sorrento Therapeutics, Inc. in Q1 2015 and held it in 15 quarters.
  • Group One Trading's Sorrento Therapeutics, Inc. position peaked at $391K in Q3 2018.
  • 219 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2020.

Based on Group One Trading's 13F filing for Q4 2020, filed 10 Feb 2021.